Globalization of Biosimilars

This track discuses about the generic drugs impact on global biosimilar market , Cost and risk management, Adopting innovative mechanisms such as risk-sharing arrangement, European market for biosimilars. The global market scenario with the launch of first biosimilar in the market forecasts some radical changes. This track will look upon such key concerns which are witnessed by the global pharma market and that are coming up with the subsequent launch of the other biosimilars and biologics. Despite these emerging facilities, biotherapeutic developers are most comfortable off-shoring to established markets—the US and Europe.

  • Biosimilar Multimodal Techniques
  • Biosimilar Electrophoresis and Formulation
  • Biosimilar GMP Protein Analysis
  • Supply Chain Challenges Before Biosimilars
Submit Abstract